82 related articles for article (PubMed ID: 37111226)
1. Efficacy and safety of Omega-3 polyunsaturated fatty acids in adjuvant treatments for colorectal cancer: A meta-analysis of randomized controlled trials.
Liu H; Chen J; Shao W; Yan S; Ding S
Front Pharmacol; 2023; 14():1004465. PubMed ID: 37144220
[No Abstract] [Full Text] [Related]
2. Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297.
Abdelrazek NA; Saleh SE; Raafat MM; Ali AE; Aboulwafa MM
AMB Express; 2024 May; 14(1):51. PubMed ID: 38704453
[TBL] [Abstract][Full Text] [Related]
3. DHA-Provoked Reduction in Adipogenesis and Glucose Uptake Could Be Mediated by Gps2 Upregulation in Immature 3T3-L1 Cells.
Grigorova N; Ivanova Z; Vachkova E; Petrova V; Penev T
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686130
[TBL] [Abstract][Full Text] [Related]
4. The Involvement of Polyunsaturated Fatty Acids in Apoptosis Mechanisms and Their Implications in Cancer.
Montecillo-Aguado M; Tirado-Rodriguez B; Huerta-Yepez S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511450
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
6. The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials.
de Freitas Rodrigues J; Philippsen HK; Dolabela MF; Nagamachi CY; Pieczarka JC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111226
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of bortezomib in human multiple myeloma cells is enhanced by combination with omega-3 fatty acids DHA and EPA: Timing is essential.
Chen J; Garssen J; Redegeld F
Clin Nutr; 2021 Apr; 40(4):1942-1953. PubMed ID: 32977994
[TBL] [Abstract][Full Text] [Related]
9. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids and cancer.
Jing K; Wu T; Lim K
Anticancer Agents Med Chem; 2013 Oct; 13(8):1162-77. PubMed ID: 23919748
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic Acid Reverses Epithelial-Mesenchymal Transition and Drug Resistance by Impairing the PI3K/AKT/ Nrf2/GPX4 Signalling Pathway in Docetaxel-Resistant PC3 Prostate Cancer Cells.
Shao ZC; Zhu BH; Huang AF; Su MQ; An LJ; Wu ZP; Jiang YJ; Guo H; Han XQ; Liu CM
Folia Biol (Praha); 2022; 68(2):59-71. PubMed ID: 36384263
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Docosahexaenoic Acid with Different Molecular Forms for Promoting Apoptosis of the 95D Non-Small-Cell Lung Cancer Cells in a PPARĪ³-Dependent Manner.
Yue H; Tian Y; Zhao Z; Bo Y; Guo Y; Wang J
Mar Drugs; 2022 Sep; 20(10):. PubMed ID: 36286423
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic Acid Delivery Systems, Bioavailability, Functionality, and Applications: A Review.
Lv W; Xu D
Foods; 2022 Sep; 11(17):. PubMed ID: 36076867
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
